About This Role
We are seeking a dynamic and experienced Director of U.S. Market Access Marketing to lead the development and execution of the U.S. market access launch plan for two high-priority pipeline assets in lupus. This is a critical leadership role responsible for shaping comprehensive access strategies, payer engagement, and cross-functional alignment to ensure successful, timely product commercialization.
This is an exciting opportunity to be at the forefront of bringing innovative therapies to patients while shaping access strategies from the ground up. You will join a purpose-driven team that values innovation, collaboration, and patient-centric thinking.
What You’ll Do
- Develop pre- and post-launch payer value propositions, messaging, and promotional materials (both branded and unbranded) tailored to key customer segments (e.g., payers, IDNs, GPOs).
- Shape the development of pricing and contracting strategies, ensuring market competitiveness and payer acceptance.
- Define and execute strategies for buy-and-bill environments, including physician-administered settings.
- Support the evaluation of trade and distribution models to optimize patient access and product availability.
- Partner with medical and HEOR to support the development of evidence generation plans aligned with payer needs.
- Lead market research and competitive intelligence to inform access strategies and positioning.
- Monitor evolving reimbursement and policy landscapes and integrate insights into access strategies.
- Drive cross-functional collaboration across global value and access and several U.S. teams including pricing, HEOR, trade & distribution, field access, medical regulatory, legal, training and commercial brand marketing teams.
- Recruit, coach and develop future market access marketing talent.
Who You Are
The ideal candidate will bring a strong background in payer marketing, pricing, trade & distribution, and buy-and-bill models, with a proven ability to drive results through collaboration and broad commercial strategic thinking. This role requires a hands-on leader who can operate both strategically and tactically to deliver impact across the full market access spectrum.
Skills You Will Need
- Minimum of 10+ years of experience in U.S. market access, payer marketing, pricing, or related fields within the pharmaceutical or biotech industry.
- Proven experience leading market access launch strategies for pipeline or newly launched products.
- Deep understanding of buy-and-bill reimbursement pathways, including provider dynamics and payer policy considerations.
- Strong knowledge of payer landscape, policy trends, trade & distribution models, and pricing frameworks.
- Exceptional leadership and cross-functional team management skills.
- Strategic mindset with strong analytical and communication capabilities.
- Ability to operate in a fast-paced, dynamic environment with a high degree of ownership and accountability.
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Biogen Cambridge, Massachusetts, USA Office
225 Binney Street, Cambridge, MA, United States, 02142
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
